Tenders Are Invited For Pharmaceutical Products

Contract Notice Pharmaceutical ProductsDelivery Of Medicines For Treatment Of Oncological Diseases Divided Into 2 Separate PositionsDescription 1 1 L02bx03 Abiraterone Acetate Oral Form Mg 6 900 000 1 2 L01xe13 Afatinib Oral Form Mg 36 960 1 3 L01xx44 Aflibercept Parenteral Form Mg 36 000 1 4 L01xe17 Axitinib Oral Form Mg 10 080 1 5 L01xc07 Bevacizumab Parenteral Form Mg 940 000 1 6 L01cd04 Cabazitaxel Parenteral Form Mg 2 160 1 7 V03af03 Calcium Folinate Parenteral Form Mg 900 000 1 8 L01bc06 Capecitabine Oral Form Mg 26 730 000 1 9 L01xa02 Carboplatin Parenteral Form Mg 450 000 1 10 L01xc06 Cetuximab Parenteral Form Mg 189 600 1 11 L01xa01 Cisplatin Parenteral Form Mg 75 000 1 12 L01xe16 Crizotinib Oral Form Mg 45 000 1 13 L01aa01 Cyclophosphamide Parenteral Form Mg 630 000 1 14 L01xe23 Dabrafenib Oral Form Mg 720 000 1 15 B03xa02 Darbepoetin Alfa Parenteral Form Mcg 50 000 1 16 M05bx04 Denosumab Parenteral Form Mg 64 800 1 17 L01cd02 Docetaxel Parenteral Form Mg 50 000 1 18 L01db01 Doxorubicin Hydrochloride Powder Dispersion And Concentrate For Dispersion For Infusion Mg 5 000 1 19 L02bb04 Enzalutamide Oral Form Mg 1 075 200 1 20 L01db03 Epirubicin Parenteral Form Mg 125 000 1 21 L01xx41 Eribulin Parenteral Form Mg 350 1 22 L01xe03 Erlotinib Oral Form Mg 200 000 1 23 B03xa01 Erythropoietin Epoetin Alfa Parenteral Form Ddd 8 640 1 24 L01cb01 Etoposide Parenteral Form Mg 139 620 1 25 L01xe10 Everolimus Oral Form Mg 50 000 1 26 L03aa02 Filgrastim Parenteral Form Miu 43 200 1 27 L01bc02 Fluorouracil Parenteral Form Mg 6 250 000 1 28 L01xe02 Gefitinib Oral Form Mg 180 000 1 29 L01bc05 Gemcitabine Parenteral Form Mg 720 000 1 30 M05ba06 Ibandronic Acid Parenteral Form Mg 360 1 31 L01aa06 Ifosfamide Parenteral Form Mg 720 000 1 32 L01xe01 Imatinib Oral Form Mg 1 029 600 1 33 L03ab04 L03ab05 Interferon Alfa Parenteral Form Miu 3 240 1 34 L01xc11 Ipilimumab Parenteral Form Mg 1 500 1 35 L01xx19 Irinotecan Parenteral Form Mg 75 000 1 36 L01xe07 Lapatinib Oral Form Mg 1 680 000 1 37 L03aa14 Lipegfilgrastim Parenteral Form Mg 432 1 38 L01db07 Mitoxantrone Parenteral Form Mg 300 1 39 L03ax03 Mycobacterium Bovis Bcg Baccilus Calmette Guerin Parenteral Form Mg 30 000 1 40 H01cb02 Octreotide Powder For Suspension For Injection Solvent Mg 4 440 1 41 L01xx46 Olaparib Capsules Mg 1 500 000 1 42 L01xx47 Olaparib Tablets Mg 1 080 000 1 43 L01xa03 Oxaliplatin Parenteral Form Mg 150 000 1 44 L01cd01 Paclitaxel Parenteral Form Mg 324 090 1 45 L01xc08 Panitumumab Parenteral Form Mg 60 000 1 46 L01xe11 Pazopanib Oral Form Mg 1 440 000 1 47 L03aa13 Pegfilgrastim Parenteral Form Mg 240 1 48 L01xc18 Pembrolizumab Parenteral Form Mg 62 400 1 49 L01ba04 Pemetrexed Concentrate For Solution For Infusion Mg 50 000 1 50 L01ba04 Pemetrexed Powder For Concentrate For Solution For Infusion Mg 50 000 1 51 L01xc13 Pertuzumab Parenteral Form Mg 201 600 1 52 L01xc21 Ramucirumab Parenteral Form Mg 30 000 1 53 L01xe05 Sorafenib Oral Form Mg 3 348 800 1 54 L01xe04 Sunitinib Oral Form Mg 111 000 1 55 L01bc53 Tegafur Gimeracil Oteracil Oral Ddd 20 Mg 5 8 Mg 15 8 Mg 2 016 1 56 L01ax03 Temozolomide Oral Form Mg 180 000 1 57 L01xe09 Temsirolimus Parenteral Form Mg 700 1 58 L01xx17 Topotecan Parenteral Form Mg 450 1 59 L01xx17 Topotecan Oral Form Mg 300 1 60 L01xc03 Trastuzumab 150 Mg Parenteral Form Mg 150 000 1 61 L01xc03 Trastuzumab 600 Mg Parenteral Form Mg 468 000 1 62 L01xc14 Trastuzumab Emtansine Parenteral Form Mg 21 840 1 63 L01xe12 Vandetanib Oral Form Mg 72 000 1 64 L01xe15 Vemurafenib Oral Form Mg 1 290 240 1 65 L01ca04 Vinorelbine Parenteral Form Mg 9 000 1 66 L01xx43 Vismodegib Oral Form Mg 352 800 1 67 M05ba08 Zoledronic Acid Parenteral Form Mg 5 600 Time Limit For Receipt Of Tenders Or Requests To Participate Date 04 10 2019 Local Time 16 00 Disclaimer The Above Text Is Machine Translated For Accurate Information Kindly Refer The Original Document

Refer document